Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: A pilot study

Maturitas

Volumn 72, Issue 1, 2012, Pages 93-94

  Del Pup, L ^a   Postruznik, D ^b   Corona, G ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NONE

Author keywords

Dyspareunia; Estrone sulphate; Female cancer patients; Promestriene; Vaginal dryness; Vaginal estrogens

Indexed keywords

ESTRONE SULFATE; PROMESTRIENE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DYSPAREUNIA; ENDOMETRIUM CANCER; ESTROGEN BLOOD LEVEL; FEMALE; GYNECOLOGIC CANCER; HUMAN; OVARY CANCER; PILOT STUDY; UTERINE CERVIX CANCER; VAGINAL DRYNESS; VULVA CANCER;

ADULT; AGED; ATROPHY; DYSPAREUNIA; ESTRADIOL; ESTROGENS; ESTRONE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; PILOT PROJECTS; SUPPOSITORIES; VAGINA; VAGINAL DISEASES;

EID: 84859532701     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.01.017     Document Type: Article

References (18)

1. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health related quality of life and sexual functioning. J Clin Oncol 1998;16:501-14. (Pubitemid 28135592)
2. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008;26(5):753-8. (Pubitemid 351264388)
3. Cardozo L, Bachmann G, McClish D, et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722-7. (Pubitemid 28440818)
4. Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas 2005;50(2):98-104.
5. Suckling JA, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women (review). Cochrane Database Syst Rev 2006;18(October (4)):CD001500.
6. Ponzone R, Biglia N, Jacomuzzi ME, Maggiorotto F, Mariani L, Sismondi P. Vaginal oestrogen therapy after breast cancer: is it safe? Eur J Cancer 2005;41:2673-81. (Pubitemid 41607558)
7. Trinkaus M, Chin S, Wolfman A, Simmons C, Clemons M. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens? The Oncologist 2008;13:222-31. (Pubitemid 351679897)
8. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
9. Labrie F, Cusan L, Gomez JL, et al. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause 2009;16(1):30-6.
10. Wolff JP, Cachelou R, Gueritée N. Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa. Maturitas 1982;4:239-46. (Pubitemid 13189092)
11. Borrelli AL, Casolaro AM, Espósito G, Berlingieri D. Attività biologica del promestriene sul tratto genitale della ratta castrata. Minerva Ginecol 1990;42(11):467-72.
12. Belaish J, Thomas JL, Lumbroso M. Esperienza francese ed europea con il promestriene. In: Bottiglioni F, editor. Il cimaterio femminile Torchio de Ricci. 1988. p. 29-44.
13. Campana G, Di Francesco G. Menopausal syndrome: clinical experiences with promestriene. Ann Ost Med Pren 1976;3:1-9.
14. Corona G, Elia C, Casetta B, et al. Liquid chromatography tandem mass spectrometry assay for fast and sensitive quantification of estrone-sulfate. Clin Chim Acta 2010;411:574-80.
15. Pschera B, Hjerpe A, Carltröm K. Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17 and progesterone in postmenopausal women. Gynecol Obstet Invest 1989;27:204-8.
16. Sun AJ, Lin SQ, Jing LH, Wang ZY, Ye JL, Zhang Y. Safety of promestriene capsule used in postmenopausal atrophic vaginitis. Chin J Obstet Gynecol 2009;44(8):593-6.
17. Rigg LA, Hermann H, Yen SC. Absorption of estrogens from vaginal creams. N Engl J Med 1978;298:195-7. (Pubitemid 8272278)
18. Pasqualini JR, Chetrite GS. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 2005;93:221-36, 44.